Does CILGAVIMAB\TIXAGEVIMAB Cause Malignant neoplasm progression? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Malignant neoplasm progression have been filed in association with CILGAVIMAB\TIXAGEVIMAB. This represents 0.5% of all adverse event reports for CILGAVIMAB\TIXAGEVIMAB.
11
Reports of Malignant neoplasm progression with CILGAVIMAB\TIXAGEVIMAB
0.5%
of all CILGAVIMAB\TIXAGEVIMAB reports
8
Deaths
1
Hospitalizations
How Dangerous Is Malignant neoplasm progression From CILGAVIMAB\TIXAGEVIMAB?
Of the 11 reports, 8 (72.7%) resulted in death, 1 (9.1%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CILGAVIMAB\TIXAGEVIMAB. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does CILGAVIMAB\TIXAGEVIMAB Cause?
Covid-19 (521)
Drug ineffective (123)
Product use issue (94)
Fatigue (86)
Headache (86)
Dyspnoea (84)
Pyrexia (81)
Nausea (68)
Dizziness (64)
Breakthrough covid-19 (51)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which CILGAVIMAB\TIXAGEVIMAB Alternatives Have Lower Malignant neoplasm progression Risk?
CILGAVIMAB\TIXAGEVIMAB vs CILOSTAZOL
CILGAVIMAB\TIXAGEVIMAB vs CILTACABTAGENE AUTOLEUCEL
CILGAVIMAB\TIXAGEVIMAB vs CIMETIDINE
CILGAVIMAB\TIXAGEVIMAB vs CIMZIA
CILGAVIMAB\TIXAGEVIMAB vs CINACALCET